Stemtech Corporation (STEK)

Market Cap	3.00K -99.9%
Revenue (ttm)	2.40M -38.6%
Net Income	-3.75M
EPS	-0.00
Shares Out	3.00B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	2.57
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2026

About Stemtech

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company’s products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 80
• Stock Exchange: OTCMKTS
• Ticker Symbol: STEK

Financial Performance

In 2025, Stemtech's revenue was $2.88 million, a decrease of -43.08% compared to the previous year's $5.05 million. Losses were -$4.05 million, 7.35% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 15, 2026

Data Sources Report a data error